Association of Reversal of Renin Suppression With Long-Term Renal Outcome in Medically Treated Primary Aldosteronism.

Sho Katsuragawa Atsushi Goto Satoru Shinoda Kosuke Inoue Kazuki Nakai Jun Saito Tetsuo Nishikawa Yuya Tsurutani

Published in: Hypertension (Dallas, Tex. : 1979) (2023)

Our findings may highlight the importance of reversing renin suppression with optimal mineralocorticoid receptor antagonist titration in medically treated primary aldosteronism, which could mitigate adverse renal outcomes.

Keyphrases

angiotensin converting enzyme
type diabetes
newly diagnosed
emergency department
skeletal muscle